MNPRNasdaq United States
Market cap
$798.595 M
$119.21 -0.83%
Close of 7 Aug 2026
Revenue
$0.00
#3658 by revenue
Earnings
-$13.7M
Loss-making
Shares outstanding
6,692,140
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Monopar Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.